Immunogenicity, safety and reactogenicity study of GlaxoSmithKline (GSK) Biologicals’ Hib-MenCY-TT (MenHibrix®) vaccine compared to Merck & Co, Inc. PedvaxHIB vaccine in healthy infants and toddlers 12 to 15 months of age, Trial ID 112931 | GSK